Non-alcoholic fatty liver disease (NAFLD), characterized by excessive hepatic lipid accumulation, poses a high prevalence and can progress to cirrhosis and liver cancer. To enhance preventive and ...

A new combined test panel called Lipid Profile ALT (Cholestech Corp., Hayward, Calif.) has received an FDA waiver from Clinical Laboratory Improvement Amendments (CLIA) standards. The panel, designed ...

A recent study published in ACS Nano explored a novel strategy to reprogram the liver’s immune environment and generate an antitumor response against metastatic pancreatic cancer. Image Credit: ...

Cholesterol crystals in the liver may stiffen the organ early in those with metabolic dysfunction-associated steatotic liver disease (MASLD)—well before scarring develops—according to new research ...

An enzyme called SCD1 has tantalized biotechs with the possibility of treating everything from liver disease to cancer. But new research may finally offer a way to confer the benefits of this ...

Scientists from the Karolinska Institute in Sweden report that immune cells in the liver react to high cholesterol levels and engulf excess cholesterol that can otherwise cause damage to arteries.

Personalized weight loss programs in obese children are shown to reduce specific harmful lipids linked to heart disease and metabolic issues, offering a promising strategy for early intervention and ...